Review Article
The Cancer Stem Cell Concept in Progression of Head and Neck Cancer
Table 1
Putative CSC makers in solid tumors.
| CSC markers | Tumor types | % CSC markers | Minimal cell no. | Refs | in tumor cells | for tumor formation |
| CD4/CD2 | Breast | 11–35 | 200 | [18] | CD4 | Head and neck | 0.1–42 | 5000 | [57] | | Prostate | 0.3–38 | 100 | [26] | CD4/EpCA | Colon | 0.03–38 | 200 | [31] | CD4/CD2/ES | Pancreas | 0.2–0.8 | 100 | [27] | ALDH | Breast | 3–10 | 500 | [71] | CD13 | Brain | 6–29 | 100 | [21] | | Brain | 2-3 | 500 | [39] | | Colon | 1.8–25 | 200 | [40] | | Colon | 0.7–6 | 3000 | [27] | | Head and neck | 0.8–4.2 | 1000 | [60] | | Pancreas | 1–3 | 500 | [32] | | Lung | 0.32–22 | | [19] | Side population | Prostate | 0.05–0.2 | 100 | [33] | ABCG | Melanoma | 1.6–20 | | [30] |
|
|